Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to investigate the pharmacodynamic effect of AZD2516 in healthy male subjects.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: AstraZeneca

Criteria

Inclusion Criteria:

• Provision of signed informed consent

• Healthy male subjects

• Age 18-45 years, inclusive

Exclusion Criteria:

• Clinically significant illness within the 2 weeks prior to the first dose of study drug

• History of clinically significant cardiovascular, respiratory, renal, hepatic, neurological, mental or gastrointestinal disease

• Need for concomitant medications during the study